Research ArticleGenetics

Mutations in Fibrillin-1 Cause Congenital Scleroderma: Stiff Skin Syndrome

See allHide authors and affiliations

Science Translational Medicine  17 Mar 2010:
Vol. 2, Issue 23, pp. 23ra20
DOI: 10.1126/scitranslmed.3000488

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


The predisposition for scleroderma, defined as fibrosis and hardening of the skin, is poorly understood. We report that stiff skin syndrome (SSS), an autosomal dominant congenital form of scleroderma, is caused by mutations in the sole Arg-Gly-Asp sequence–encoding domain of fibrillin-1 that mediates integrin binding. Ordered polymers of fibrillin-1 (termed microfibrils) initiate elastic fiber assembly and bind to and regulate the activation of the profibrotic cytokine transforming growth factor–β (TGFβ). Altered cell-matrix interactions in SSS accompany excessive microfibrillar deposition, impaired elastogenesis, and increased TGFβ concentration and signaling in the dermis. The observation of similar findings in systemic sclerosis, a more common acquired form of scleroderma, suggests broad pathogenic relevance.


  • * These authors contributed equally to this work.

  • Citation: B. L. Loeys, E. E. Gerber, D. Riegert-Johnson, S. Iqbal, P. Whiteman, V. McConnell, C. R. Chillakuri, D. Macaya, P. J. Coucke, A. De Paepe, D. P. Judge, F. Wigley, E. C. Davis, H. J. Mardon, P. Handford, D. R. Keene, L. Y. Sakai, H. C. Dietz, Mutations in Fibrillin-1 Cause Congenital Scleroderma: Stiff Skin Syndrome. Sci. Transl. Med. 2, 23ra20 (2010).

View Full Text

Stay Connected to Science Translational Medicine